Tobacco consumption is a reversible risk factor associated with reduced successful treatment outcomes of anti-tuberculosis therapy

Yi Chun Chiang, You Meei Lin, Jen Ai Lee, Chun-Nin Lee, Hsiang Yin Chen

研究成果: 雜誌貢獻文章

13 引文 (Scopus)

摘要

Objective: The aim of this study was to evaluate the reversible factors that could possibly affect outcomes of anti-tuberculosis (anti-TB) treatment. Methods: A retrospective observational nested case-control study was performed to evaluate the association of patient and clinical factors with anti-TB therapy outcomes as defined by the World Health Organization (WHO). Results: To examine the impact of a variety of factors on the outcomes of anti-TB treatment, a total of 302 TB patients were included in the study. Univariate analysis revealed that age, gender, concurrent hypertension, asthma/chronic obstructive pulmonary disease, or liver disease, worsened baseline blood urea nitrogen or creatinine, ethambutol 20 cigarettes per day) was significantly associated with a decreased odds of cure or treatment completion (odds ratio 0.23, 95% confidence interval 0.05-0.98, p= 0.047). Conclusions: As smoking significantly inhibits the effectiveness of TB treatment, the integration of smoking cessation into TB treatment programs is strongly advocated to reduce the dual global burden of smoking and TB.
原文英語
期刊International Journal of Infectious Diseases
16
發行號2
DOIs
出版狀態已發佈 - 二月 2012

指紋

Tobacco Use
Tuberculosis
Smoking
Therapeutics
Ethambutol
Blood Urea Nitrogen
Smoking Cessation
Tobacco Products
Chronic Obstructive Pulmonary Disease
Case-Control Studies
Liver Diseases
Creatinine
Asthma
Odds Ratio
Confidence Intervals
Hypertension

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

引用此文

@article{76b139ee312c4506aa3e330287cb00af,
title = "Tobacco consumption is a reversible risk factor associated with reduced successful treatment outcomes of anti-tuberculosis therapy",
abstract = "Objective: The aim of this study was to evaluate the reversible factors that could possibly affect outcomes of anti-tuberculosis (anti-TB) treatment. Methods: A retrospective observational nested case-control study was performed to evaluate the association of patient and clinical factors with anti-TB therapy outcomes as defined by the World Health Organization (WHO). Results: To examine the impact of a variety of factors on the outcomes of anti-TB treatment, a total of 302 TB patients were included in the study. Univariate analysis revealed that age, gender, concurrent hypertension, asthma/chronic obstructive pulmonary disease, or liver disease, worsened baseline blood urea nitrogen or creatinine, ethambutol 20 cigarettes per day) was significantly associated with a decreased odds of cure or treatment completion (odds ratio 0.23, 95{\%} confidence interval 0.05-0.98, p= 0.047). Conclusions: As smoking significantly inhibits the effectiveness of TB treatment, the integration of smoking cessation into TB treatment programs is strongly advocated to reduce the dual global burden of smoking and TB.",
keywords = "Drug therapy, Risk factors, Smoking, Treatment outcome, Tuberculosis",
author = "Chiang, {Yi Chun} and Lin, {You Meei} and Lee, {Jen Ai} and Chun-Nin Lee and Chen, {Hsiang Yin}",
year = "2012",
month = "2",
doi = "10.1016/j.ijid.2011.10.007",
language = "English",
volume = "16",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Tobacco consumption is a reversible risk factor associated with reduced successful treatment outcomes of anti-tuberculosis therapy

AU - Chiang, Yi Chun

AU - Lin, You Meei

AU - Lee, Jen Ai

AU - Lee, Chun-Nin

AU - Chen, Hsiang Yin

PY - 2012/2

Y1 - 2012/2

N2 - Objective: The aim of this study was to evaluate the reversible factors that could possibly affect outcomes of anti-tuberculosis (anti-TB) treatment. Methods: A retrospective observational nested case-control study was performed to evaluate the association of patient and clinical factors with anti-TB therapy outcomes as defined by the World Health Organization (WHO). Results: To examine the impact of a variety of factors on the outcomes of anti-TB treatment, a total of 302 TB patients were included in the study. Univariate analysis revealed that age, gender, concurrent hypertension, asthma/chronic obstructive pulmonary disease, or liver disease, worsened baseline blood urea nitrogen or creatinine, ethambutol 20 cigarettes per day) was significantly associated with a decreased odds of cure or treatment completion (odds ratio 0.23, 95% confidence interval 0.05-0.98, p= 0.047). Conclusions: As smoking significantly inhibits the effectiveness of TB treatment, the integration of smoking cessation into TB treatment programs is strongly advocated to reduce the dual global burden of smoking and TB.

AB - Objective: The aim of this study was to evaluate the reversible factors that could possibly affect outcomes of anti-tuberculosis (anti-TB) treatment. Methods: A retrospective observational nested case-control study was performed to evaluate the association of patient and clinical factors with anti-TB therapy outcomes as defined by the World Health Organization (WHO). Results: To examine the impact of a variety of factors on the outcomes of anti-TB treatment, a total of 302 TB patients were included in the study. Univariate analysis revealed that age, gender, concurrent hypertension, asthma/chronic obstructive pulmonary disease, or liver disease, worsened baseline blood urea nitrogen or creatinine, ethambutol 20 cigarettes per day) was significantly associated with a decreased odds of cure or treatment completion (odds ratio 0.23, 95% confidence interval 0.05-0.98, p= 0.047). Conclusions: As smoking significantly inhibits the effectiveness of TB treatment, the integration of smoking cessation into TB treatment programs is strongly advocated to reduce the dual global burden of smoking and TB.

KW - Drug therapy

KW - Risk factors

KW - Smoking

KW - Treatment outcome

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84856008496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856008496&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2011.10.007

DO - 10.1016/j.ijid.2011.10.007

M3 - Article

VL - 16

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 2

ER -